• Nenhum resultado encontrado

Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It.

N/A
N/A
Protected

Academic year: 2017

Share "Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It."

Copied!
10
0
0

Texto

Loading

Imagem

Table 1. Baseline characteristics of MDR-TB patients on treatment, LFU and non-LFU patients at Drug Resistant TB Centre in Vadodara, Gujarat, India.
Table 2. MDR-TB treatment outcomes of patients at at Drug Resistant TB Centre in Vadodara, Gujarat, India.
Table 3. Factors associated with LFU among MDR-TB patients on treatment at Drug Resistant TB Centre in Vadodara, Gujarat, India.

Referências

Documentos relacionados

analysis, data related to participants who did not expe- rience the event by the end of the study or were lost to follow-up are censored: they contribute to the analysis up to

Purpose: We classiied patients lost to follow-up after mid urethral synthetic sling placement as examples of treatment success or failure based on the Patient Global Impression

Objective: To determine the incidence of active tuberculosis (TB) among individuals cohabiting with patients infected with susceptible and multidrug-resistant tuberculosis

Regarding the follow-up treatment of asthma, the patients were asked whether they had ever been referred for outpatient treatment in the intervals between asthma

The aim of this study was to analyze the self-rated health and its association with sex, age, socioeconomic status and characteristics related to the treatment among AIDS

Portanto, é importante que os funcionários das farmácias e drogarias, os médicos, enfermeiros e farmacêuticos das unidades básicas de saúde, assim como

The main observations in this study were: (a) age 50 years or older is associated with lower risk of loss to follow-up and death in the course of treatment when compared to cases

The objective of this study was to develop a molecular platform to make a rapid diagnosis of multidrug-resistant (MDR) and extensively drug-resistant TB based on single